Navigation Links
Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results

which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.

    Contact:    William R. LaRue
                SVP & Chief Financial Officer
                Cadence Pharmaceuticals, Inc.
                Phone : 858-436-1400

                           CADENCE PHARMACEUTICALS, INC.
                           (a development stage company)

                          Three Months Ended          Nine Months Ended
                             September 30,              September 30,
                          ------------------          -----------------
                          2009          2008          2009         2008
                          ----          ----          ----         ----
    Operating expenses:
      Research and
       development     $4,924,778   $10,241,943   $15,144,099   $32,463,211
      Sales and
       marketing        2,608,441       664,143     4,330,695     2,175,120
      General and
       administrative   3,762,851     2,754,064     9,549,203     8,323,996
      Other                  (944)          509       412,141        28,766
                             ----           ---       -------        ------
         expenses      11,295,126    13,660,659    29,436,138    42,991,093
                       ----------    ----------    ----------    ----------

    Loss from
     operations       (11,295,126)  (13,660,659)  (29,436,138)  (42,991,093)

    Other (
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the JMP Securities Healthcare Focus Conference in New York on October 6, 2009
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Canaccord Adams Global Growth Conference in Boston on August 11, 2009
3. Cadence Pharmaceuticals Announces Priority Review and Acceptance of NDA Submission for Acetavance(TM) for Treatment of Acute Pain and Fever
4. Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
6. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2009 Financial Results on May 7, 2009
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Cowen & Companys 29th Annual Health Care Conference in Boston on March 16, 2009
8. Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock
9. Cadence Pharmaceuticals to Raise $86.6 Million in a Private Placement of Common Stock
10. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
11. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Post Your Comments:
(Date:7/23/2014)... Agricultural and Forestry University in Shaanxi province, and the ... agreement that lays the groundwork for establishing the Sino-U.S. ... The signing ceremony was held in the city of ... the U.S. Department of Agriculture and China,s Ministry of ... event for UC Davis and for our World Food ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 Rich Dad® ... the success of their charity yard sale to support Habit ... raised and 100% of the proceeds will be donated to ... the event are being donated to the Habitat for Humanity ... Myers, Florida 33903. , One of the highlights of ...
(Date:7/23/2014)... CA (PRWEB) July 23, 2014 Global ... delivering Enhanced External Counterpulsation (EECP), is celebrating ... receives EECP therapy at the health center. , ... heart disease. Since receiving ongoing EECP therapy since 1999, ... When Sara Soulati, CEO of Global Cardio Care, introduced ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014, ... largest online retailer of nutritional supplements, has officially opened ... BPI SPORTS , the fastest growing sports nutrition ... categories: , Brand of the Year, Best Tasting Protein ... Year, Protein Powder of the year - Whey-HD™, Pre-workout ...
(Date:7/23/2014)... secrets to better treating the pernicious disorders of obesity ... paper from American University,s Center for Behavioral Neuroscience. In ... with therapies aimed at areas of the brain responsible ... the hippocampus could play a role in reducing certain ... and preventive measures often fall short. This is a ...
Breaking Medicine News(10 mins):Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Supplement Awards 3Health News:Targeting the brain to treat obesity 2Health News:Targeting the brain to treat obesity 3
... This month, Pakistan is introducing a new combination vaccine ... influenzae type b (Hib) and four other common childhood ... deadly meningitis and pneumonia, is one of the top ... with treatment, an estimated 23,000 children die of Hib ...
... Calif., Oct. 31 David J. Pecker,Chairman and ... Chris,Lockwood, Mike Carlson, and Allan Donnelly have joined ... Muscle & Fitness Hers magazines, reporting to,Laya Clark ... of AMI,s Enthusiast Group. The Group includes these ...
... blood transfusions,3-year recovery, NEW YORK, Oct. 31 ... Matthew Long, a blood transfusion,recipient, to the New York ... City firefighter, former triathlete and competitive marathoner, was,critically injured ... bus while,biking to work on December 23, 2005. He ...
... Pregnant women whose labor stalls while in the active phase ... infants by waiting out the delivery process for an extra ... the University of California, San Francisco. , By doing ... the more dangerous and expensive surgical approach per year ...
... calorie burn , , FRIDAY, Oct. 31 (HealthDay News) -- ... stimulant produced by the human body has been discovered. ... antibody catalyst, GHR-11E11, increased the metabolic rate in fasting ... went 24 hours without food. , The antibody counteracts ...
... in this group , , FRIDAY, Oct. 31 (HealthDay News) ... death among kidney failure patients, and inflammation and malnutrition ... these people, Johns Hopkins researchers report. , The researchers ... on dialysis. Over 9.5 years, there were 658 deaths, ...
Cached Medicine News:Health News:Pakistan introduces vaccine to prevent top child killer 2Health News:American Media Inc. Names Chris Lockwood, Mike Carlson, and Allan Donnelly to Lead Editorial Teams at Enthusiast Group of Fitness Titles 2Health News:Blood Recipient Matthew Long Returns to New York Marathon 2Health News:Patience during stalled labor can avoid many C-sections, UCSF study shows 2Health News:Scientists Develop New Strategy to Fight Obesity 2Health News:Kidney Patients More Susceptible to Sudden Cardiac Death 2
(Date:7/23/2014)... July 23, 2014 The Board of Directors ... leading provider of clinical trial imaging solutions, announced today ... named president and chief executive officer, effective immediately.  Mr. ... 2013 and has held the positions of interim president ... Dr. Charles E. Phelps , Ph.D., chairman ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC ... company,s chief customer officer effective immediately. Toll recently served ... sales and marketing, category management, private label and sales ... In his new global role, Toll will expand his ... sales planning. "Toll,s appointment to chief customer ...
(Date:7/23/2014)... , July 23, 2014  RT Oncology Services Corporation ... to join its board of directors. Mr. Mundie is ... where he works on strategic projects within the company ... Microsoft,s chief research and strategy officer. ... of RainTree, said, "Craig is a visionary technology executive. ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4Craig Mundie Joins RainTree Oncology Board of Directors 2Craig Mundie Joins RainTree Oncology Board of Directors 3
Fome-Cuf® tubes can breathe with the patient to provide a safe, effective, and low pressure seal throughout the ventilatory cycle....
Portex® pediatric tracheostomy tubes offer a choice in both form and fit. , ,The anatomical shape of the tube shaft along with the caudal angle of the 15 mm connector provide comfort and security...
Indications For Usage: ,Bypass upper airway obstructions, provide long term ventilation, support and/or manage tracheal/bronchial secretions....
KIMBERLY-CLARK BALLARD Neonatal and Pediatric TRACH CARE Manifold features lavage/irrigation port and locking thumb port. Multiple French sizes and packaging configurations. Gamma sterilized....
Medicine Products: